TRACKER, a comprehensive range on the market allowing all patients treated with Infliximab to be monitored Croissy-Beaubourg, February 13, 2020, 5:45pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics…
2019 revenue up 10.5% for Theranostics and up 6% for IVD Excellent performance for Theranostics, particularly in France, with 19% growth11% overall growth in sales of LISA TRACKER® kits for routine useCash position at December…
Croissy-Beaubourg, January 29, 2020, 8:00am CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics of autoimmune diseases and theranostics, will publish its 2019 consolidated Full-year annual revenue and its cash…